IRVINE, CA--(Marketwired - Jun 7, 2013) - BIOLASE, Inc. (
The four directors elected with more than 98 percent of shares voted at the meeting to serve until the next annual meeting are Chairman and CEO Federico Pignatelli; Alexander K. Arrow, M.D., most recently Chief Medical and Strategic Officer of Circuit Therapeutics, Inc., Gregory E. Lichtwardt, Executive Vice President, Treasurer, and CFO of Conceptus, Inc.; and Norman J. Nemoy, M.D., a partner of Tower Urology Medical Group.
About BIOLASE, Inc. BIOLASE, Inc. is a biomedical company that develops, manufactures, and markets innovative lasers in dentistry and medicine and also markets and distributes high-end 2D and 3D digital imaging equipment and CAD/CAM intraoral scanners; products that are focused on technologies that advance the practice of dentistry and medicine . The Company's proprietary laser products incorporate over 350 patented and patent-pending technologies designed to provide biologically clinically superior performance with less pain and faster recovery times. Its imaginative products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. BIOLASE ® has sold more than 22,500 lasers. Other laser products under development address ophthalmology and other medical and consumer markets.
For updates and information on WaterLase ® and laser dentistry, find BIOLASE online at www.biolase.com , Facebook at www.facebook.com/biolaseinc , Twitter at www.twitter.com/biolaseinc , Pinterest at www.pinterest.com/biolase , LinkedIn at www.linkedin.com/company/biolase , Instagram at www.instagram.com/biolaseinc and YouTube at www.youtube.com/biolasevideos .
BIOLASE ® and WaterLase ® are registered trademarks of BIOLASE, Inc.
For further information, please contact: Michael Porter Porter, LeVay & Rose, Inc. 212-564-4700